Abstract: Described are various embodiments of a risk assessment method and project management system using same. In some embodiments, the system is operable, for each set of risk factors in at least one set of risk factors in a project, to compute a baseline and an overrun contingency reserve corresponding to the associated risk acceptance policy of said each set of risk factors and to a designated assessment metric; and combine said baseline and said overrun contingency reserve for each of said at least one set of risk factors into a single program baseline and program overrun contingency reserve, respectively. The overrun contingency reserve from a probability distribution at said associated risk acceptance policy comprises computing an overrun tail expectation of said single probability distribution above said baseline at a (1??) significance level corresponding to said risk acceptance policy z(?).

Abstract: The present invention concerns the gelation of an undenatured protein and a polysaccharide dispersions by a gradual pH adjustment of their mixture The final pH of the mixture is close to or lower than the isoelectric point of the protein when anionic polysaccharides are used. In the present invention, the undenatured protein and the polysaccharide in the gel state have net opposite electric charges. The concentration of protein and polysaccharide preferably ranges from 0.02 to 10 wt %. The present invention also concerns a gel obtained by this method.

Abstract: The present invention relates to a process using dynamic high-pressure for inactivation of food pathogens. Liquid food are treated by dynamic-high-pressure at 1 to 5 kbars with at least one recirculation depending on the needs. The pasteurization process is performed at relatively cold temperature ranging from 4° C. to 55° C.

Abstract: The present invention relates to a process of making particles for cutaneous application or oral delivery of bioactive molecules or living systems. The process can be carried out in some simple steps. The present invention further discloses a new physiological composition allowing release different nutraceutical, biological, cosmetic, cosmeceutical, or therapeutical compounds in a human, an animal, or a composition.

Abstract: The present invention relates to a continuous process for denaturation of proteins, which comprises the steps of: a) subjecting a protein solution to a high pressure homogenizer at a pressure of about 500 to about 5000 bar, at a recirculation ranging from 0 to about 50 and at a temperature ranging from about 20° C. to about 80° C. for a period of time on the order of milliseconds, wherein the protein solution consisting of a protein fraction dispersed in water, buffer or salt solution at a concentration ranging from about 2% to about 35% w/w and at a pH adjusted between about 2.0 to about 12.0; b) concentrating the protein solution by i) evaporation, ii) ultrafiltration and sprayed dried or iii) ultrafiltration and freeze dried.